agrylin capsule 0.5 mg
takeda pharmaceuticals (asia pacific) pte. ltd. - anagrelide (as hcl) - capsule - 0.61mg - anagrelide (as hcl) 0.61mg
anagrid 0.5
rafa laboratories ltd - anagrelide as hydrochloride - capsules - anagrelide as hydrochloride 0.5 mg - anagrelide - anagrelide - indicated for the treatment of patients with essential thrombocythemia to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms.
xagrid
shire pharmaceutical contracts limited - anagrelide - thrombocythemia, essential - antineoplastic agents - xagrid is indicated for the reduction of elevated platelet counts in at-risk essential-thrombocythaemia (et) patients who are intolerant to their current therapy or whose elevated platelet counts are not reduced to an acceptable level by their current therapy.
xagrid 500microgram capsules
shire pharmaceuticals ltd - anagrelide hydrochloride - capsule - 500microgram
anagrelide 500microgram capsules
consilient health ltd - anagrelide hydrochloride - capsule - 500microgram
anagrelide mylan
mylan pharmaceuticals limited - anagrelide hydrochloride - thrombocythemia, essential - antineoplastic agents - anagrelide is indicated for the reduction of elevated platelet counts in at risk essential thrombocythaemia (et) patients who are intolerant to their current therapy or whose elevated platelet counts are not reduced to an acceptable level by their current therapy.an at-risk patientan at-risk essential thrombocythaemia patient is defined by one or more of the following features:>60 years of age ora platelet count >1,000 x 10⁹/l ora history of thrombo-haemorrhagic events.
anagrelide
kent pharmaceuticals limited - anagrelide - capsules hard - 0.5 milligram - anagrelide
anagrelide 0.5 mg hard capsules
athlone laboratories ltd - anagrelide - capsule, hard - 0.5 milligram(s) - other antineoplastic agents; anagrelide
anagrelide 0.5 mg hard capsules
athlone pharmaceuticals limited - anagrelide - capsule, hard - other antineoplastic agents; anagrelide
agrylin 0.5 mg
medison pharma ltd - anagrelide hydrochloride 0.5 mg - capsules - anagrelide - indicated for the treatment of patients with essential thrombocythemia to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms.